Citation: | ZHANG Jiong, WANG Jia, WANG Fang, LI Gui-sen. Protective effect of erythropoietin preconditioning on kidney ischemia-reperfusion injury[J]. Journal of Clinical Nephrology, 2017, 17(9): 564-568. DOI: 10.3969/j.issn.1671-2390.2017.09.012 |
[1] |
Kusch A, Hoff U, Bubalo G, et al. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury[J]. Acta Physiol(Oxf), 2013, 208(1):25-40.
|
[2] |
Yang Y, Song M, Liu Y, et al. Renoprotective approaches and strategies in acute kidney injury[J]. Pharmacol Ther, 2016, 163:58-73.
|
[3] |
de Haan JE, Hoorn EJ, de Geus HRH. Acute kidney injury after liver transplantation:Recent insights and future perspectives[J]. Best Pract Res Clin Gastroenterol, 2017, 31(2):161-169.
|
[4] |
Francis A, Baynosa R. Ischaemia-reperfusion injury and hyperbaric oxygen pathways:a review of cellular mechanisms[J]. Diving Hyperb Med, 2017, 47(2):110-117.
|
[5] |
Yang J, Xiao Z, Li T, et al. Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis[J]. Int J Oncol, 2012, 40(4):1230-1237.
|
[6] |
Bartnicki P, Kowalczyk M, Rysz J. The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection[J]. Med Sci Monit, 2013, 19(1):599-605.
|
[7] |
Nairz M, Sonnweber T, Schroll A, et al. The pleiotropic effects of erythropoietin in infection and inflammation[J]. Microbes Infect, 2012, 14(3):238-246.
|
[8] |
Zhang J, Zou YR, Zhong X, et al. Erythropoietin pretreatment ameliorates renal ischaemia-reperfusion injury by activating PI3K/Akt signalling[J]. Nephrology (Carlton), 2015, 20(4):266-272.
|
[9] |
Ardalan MR, Estakhri R, Hajipour B, et al. Erythropoietin ameliorates oxidative stress and tissue injury following renal ischemia/reperfusion in rat kidney and lung[J]. Med Princ Pract. 2013, 22(1):70-74.
|
[10] |
Li Y, Zhu W, Tao J, et al. Fasudil protects the heart against ischemia-reperfusion injury by attenuating endoplasmic reticulum stress and modulating SERCA activity:the differential role for PI3K/Akt and JAK2/STAT3 signaling pathways[J]. PloS One, 2012, 7(10):e48115.
|
[11] |
Bamgbola OF. Spectrum of anemia after kidney transplantation:pathophysiology and therapeutic implications[J]. Clin Transplant, 2016, 30(10):1185-1194.
|
[12] |
Doi K, Rabb H. Impact of acute kidney injury on distant organ function:recent findings and potential therapeutic targets[J]. Kidney Int, 2016, 89(3):555-564.
|
[13] |
Palagani V, Bozko P, El Khatib M, et al. Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression[J]. Carcinogenesis, 2014, 35(4):859-866.
|
[14] |
Yu HC, Qin HY, He F, et al. Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling[J]. Hepatology, 2011, 54(3):979-988.
|
[15] |
Zhu H, Zou L, Tian J, et al. SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway[J]. Eur J Pharmacol, 2013, 714(1-3):23-31.
|